Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 33, 102081
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2013
- Review and update of central serous chorioretinopathyCurrent Opinion in Ophthalmology, 2011
- COMPARISON OF EFFICACY AND SAFETY BETWEEN HALF-FLUENCE AND FULL-FLUENCE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2011
- Photodynamic therapy for steroid-associated central serous chorioretinopathyBritish Journal of Ophthalmology, 2010
- Standard-Fluence versus Low-Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Nonrandomized Clinical TrialAmerican Journal of Ophthalmology, 2010
- Half-Dose Verteporfin Photodynamic Therapy for Acute Central Serous ChorioretinopathyOphthalmology, 2008
- SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYRetina, 2008
- Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot studyBritish Journal of Ophthalmology, 2006
- The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathyAmerican Journal of Ophthalmology, 2005
- Long-term follow-up of central serous chorioretinopathy.British Journal of Ophthalmology, 1984